MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Fulgent Genetics Operating Expenses 2011-2026 | FLGT
Annual Operating Expenses Fulgent Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 M | 300 M | 188 M | 101 M | 41.7 M | 18.8 M | 15.7 M | 13.7 M | 10.6 M | 9.52 M | 1.33 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 300 M | 1.33 M | 80.2 M |
Quarterly Operating Expenses Fulgent Genetics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.9 M | 54.1 M | 48.1 M | - | 43.8 M | 45.4 M | 43.9 M | - | 39.6 M | 40.4 M | 43.6 M | - | 45.7 M | 52.5 M | 40.6 M | 38.7 M | 25.1 M | 18.9 M | 18.4 M | 17.3 M | 11.9 M | 6.91 M | 5.61 M | 5.16 M | 4.95 M | 4.51 M | 4.22 M | 3.93 M | 3.86 M | 3.86 M | 4.08 M | 3.81 M | 3.72 M | 2.91 M | 3.23 M | 2.73 M | 3.56 M | 1.59 M | 2.75 M | 7.52 M | 807 K | 663 K | 530 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.1 M | 530 K | 19 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
National Research Corporation
NRC
|
38.5 M | $ 14.08 | 7.32 % | $ 346 M |  USA |
 |
Agilent Technologies
A
|
1.99 B | $ 118.42 | -1.76 % | $ 36 B | USA |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.88 | -1.03 % | $ 93.5 K | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 21.65 | -1.5 % | $ 234 M |  China |
 |
Celcuity
CELC
|
113 M | $ 115.45 | 2.91 % | $ 4.55 B | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 28.07 | -0.35 % | $ 780 M | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 180.64 | 0.59 % | $ 8.95 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Co-Diagnostics
CODX
|
45.3 M | - | - | $ 79.8 M | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
106 M | $ 15.54 | 1.57 % | $ 2.02 B | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.12 | -2.61 % | $ 1.42 M | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 204.63 | -1.83 % | $ 22.7 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 201.84 | -1.41 % | $ 144 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.3 B | $ 619.18 | -4.55 % | $ 49.8 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | $ 103.5 | - | $ 19.5 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 128.64 | -0.26 % | $ 20.5 B | USA |
 |
Bioventus
BVS
|
217 M | $ 9.12 | 7.67 % | $ 571 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 9.75 | 3.72 % | $ 277 M |  Israel |
 |
DexCom
DXCM
|
1.89 B | $ 70.84 | -2.83 % | $ 27.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 110.95 | 0.68 % | $ 9.15 B |  Irlanda |
 |
Lantheus Holdings
LNTH
|
123 M | $ 76.0 | -2.37 % | $ 5.13 B | USA |
 |
CareDx, Inc
CDNA
|
411 M | $ 18.73 | -1.73 % | $ 998 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 275.55 | -1.89 % | $ 22.9 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
226 M | $ 92.64 | -0.41 % | $ 11.6 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 177.73 | -0.08 % | $ 30.6 B | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 266.36 | -1.58 % | $ 26.1 B |  Schweiz |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 12.67 | 1.77 % | $ 99.4 M | Israel |
 |
Myriad Genetics
MYGN
|
964 M | $ 5.14 | -2.72 % | $ 476 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 9.12 | 0.22 % | $ 1.17 B | USA |
 |
Natera
NTRA
|
258 M | $ 197.81 | -2.57 % | $ 19.5 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |